AbbVie posts results for Japan CLL/SLL study; also files new Phase 3 NSCLC trial vs pembrolizumabOct 23Weekly roundup, 6 itemsABBV-1480AbbVieUpdated
AbbVie terminates Phase 1b liver cancer trial of livmoniplimab plus budigalimab in ChinaOct 21Trial updateAbbViebudigalimab
Sign inSign in